Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.


Clinical Trial Description

n/a


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT01495715
Study type Interventional
Source Santhera Pharmaceuticals
Contact
Status Withdrawn
Phase Phase 3

See also
  Status Clinical Trial Phase
Completed NCT01421381 - RHODOS Follow-up Single-visit Study N/A
Completed NCT00747487 - Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy Phase 2
Completed NCT04909398 - Pupil Dynamics and Color Vision for the Detection of Eye Diseases N/A
Completed NCT02693119 - A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy Phase 2
Active, not recruiting NCT02161380 - Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy Phase 1
No longer available NCT02300753 - Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] N/A
No longer available NCT04381091 - Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study